Format

Send to

Choose Destination
Lancet. 2003 Apr 5;361(9364):1197-204.

Psoriasis.

Author information

1
Department of Dermatology, Mount Sinai School of Medicine, New York, NY 10029, USA. lebwohll@aol.com <lebwohll@aol.com>

Abstract

Recent breakthroughs in the treatment of psoriasis have led to improved understanding of the pathogenesis of this disease. Activation of T lymphocytes leading to release of cytokines results in proliferation of keratinocytes. Several new biological therapies have been developed, which target specific steps in the pathogenesis of psoriasis. With these new treatments, variable degrees of clearing occur. Initial data suggest improved safety over older agents such as methotrexate and ciclosporin, but long-term data are necessary. Enhancements in topical therapy and phototherapy have also increased the armamentarium of treatments available for this disorder.

PMID:
12686053
DOI:
10.1016/S0140-6736(03)12954-6
[Indexed for MEDLINE]

Supplemental Content

Full text links

Icon for Elsevier Science
Loading ...
Support Center